RCSI Researchers Create New Model To Identify Chemotherapy Success

Researchers at the Royal College of Surgeons Ireland say that they have developed a mathematical model which could help identify if chemotherapy will work on individual patient’s cancers.

The model has been created in order to predict how the chemotherapy process will affect triple-negative breast cancer cells. It’s hoped that by using this method, patients who will not respond well to chemotherapy will avoid the treatment and its harmful side effects.

Over 250 people in Ireland are diagnosed with the particular strain of breast cancer each year.

Dr Federico Lucantoni is the lead researcher for the project and he hopes the model can help sufferers.

“We hope that in the future clinicians by using these models will be able to tailor the therapy.”

“”It works quite well on in-vitro models on cancer cell lines,” he says, “we tested it on different triple negative breast cancer cells.”

The study was funding by the Irish Cancer Society as part of its Breast-Predict collaborative project between researchers at RCSI, UCC, NUIG, TCD, UCD and DCU.

“This paper highlights vital work being undertaken to identify new ways to improve the treatment of cancer.” said Dr Robert O’Connor, the head of cancer research for the ICS.

“This research is in quite early stages and it will be many more years until any potential benefits reach cancer patients.

“But it does show the building blocks required to lay the foundations for life-saving cancer research.”

The Irish Cancer Society’s annual Daffodil Day fundraiser will be held this Friday, March 23. The organisation’s volunteers will be patrolling the streets, hosting coffee mornings and holding community events in order to raise money for further cancer research.

You can make a Daffodil Day donation today here.